In the treatment of rheumatism arthritis, a complex and persistent self-immunological disease, several key issues warrant special attention, relating to its effectiveness and the quality of life of the patient.
First, early diagnosis and timely treatment are essential. In the early stages of the disease, the symptoms may be hidden and easily ignored by the patients, such as occasional joint pains, mild morning strangulations, etc., many mistakenly assumed to be the result of fatigue or cooling. However, the early period is exactly the golden period of control of the development of the disease, and once missed, it will become more difficult for follow-up treatment to continue to develop as the disease progresses, with a steady increase in the growth of the joints and the accumulation of inflammations, and the gradual emergence of joint swelling and deformities. Therefore, raising public awareness of early symptoms of the disease and prompting people with suspicious symptoms to undergo a thorough medical examination as soon as possible, such as through the detection of indicators such as rheumatist factors, anti-accumulon-diagnostics, etc., and an accurate diagnosis in combination with joint image performance, is the first step towards effective treatment.
Second, drug choice and rational use are central. There are a wide range of drugs available to treat rheumatism-type arthritis, ranging from traditional anti-regular drugs, such as ammonium butterflies, to fluorine, to new biological agents and small molecular targeting drugs. However, each drug has its adaptive certificate, its taboo and its potential adverse effects. For example, acetamonia, although it has had a good effect in controlling the condition, the long-term use of functions that may affect the liver, bone marrow, etc., requires regular monitoring of indicators such as blood protocol, liver function, etc. Biological agents, while effective and relevant, can be relatively expensive, and some patients may also experience inoculations or increased risk of infection. Doctors must take into account, inter alia, the seriousness of the patient ‘ s condition, his or her physical condition, financial conditions, and tailor well-defined drug programmes, while patients must strictly follow the medical instructions and must not reduce or stop the medication.
Furthermore, emphasis is placed on comprehensive treatment and rehabilitation. Treatment should not be based solely on drugs, but should also be combined with physical treatment, such as heat dressing, massages, acupuncture, etc., which would help to improve the local blood circulation of joints, alleviate pain and rigid symptoms. Rehabilitation exercise is essential and appropriate joint activity, such as handshakes, knee stretches, bends, etc., can sustain joint activity, enhance muscle strength around the joint, and prevent muscle atrophy and further joint malformation. However, exercise must be gradual and proportionate and avoid overwork and injury.
Moreover, psychological care cannot be ignored. Rheumatism arthritis is a chronic disease of long duration and repertoire, and patients often have negative feelings of anxiety, depression, etc., due to physical pain, limited ability to provide for themselves, which in turn affect the condition and dependence of treatment. Families and health-care providers need to give more attention and encouragement to help people to build confidence in overcoming disease.
In general, in the treatment of rheumatism arthritis, comprehensive attention to these issues is needed to better help patients control their condition and improve their quality of life.
